Register
Login:
Share:
Email Facebook Twitter

Tower CEO gives give operational update on Njonji development well Watch Here

Exclusive: InfraStrata CEO confirms 6 parties interested in offtake agreements
Tower CEO gives give operational update on Njonji development well


Glaxosmithkline Share Price (GSK)



Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,562.00Bid: 1,563.60Ask: 1,564.20Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.60Spread as %: 0.04%Open: 1,561.80High: 1,578.40Low: 1,542.60Yesterday’s Close: 1,562.00

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1562.00
Share Price SpacerBid
1563.60
Share Price SpacerAsk
1564.20
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
7,806,384
Share Price SpacerOpen
1,561.80
Share Price SpacerHigh
1,578.40
Share Price SpacerLow
1,542.60
Share Price SpacerClose
1,562.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,919.00m £76,834.78m 1,500

52 Week High 1,625.00 52 Week High Date 21-AUG-2018
52 Week Low 1,236.40 52 Week Low Date 6-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
13,100 3,037,602 3,802,469 49.745 31.40 80.00 5.12


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: Lloyds, BP, Vodafone, Tesco, Barclays, RBS, HSBC, National Grid, BT, Aviva

Users who hold GSK also hold: Vodafone, BP, Lloyds, National Grid, Royal Dutch Shell B, Tesco, HSBC, Aviva, Centrica, BT


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

16-Nov-18
18:45:10
1,561.774
5,156
Sell* 
1,563.60
1,564.20
80.53k
Trade Type:
Ordinary

16-Nov-18
18:45:10
1,561.774
1,606
Sell* 
1,563.60
1,564.20
25.08k
Trade Type:
Ordinary

16-Nov-18
17:10:41
1,562.00
10,954
Sell* 
1,563.60
1,564.20
171.10k
Trade Type:
Ordinary
Delayed publication




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
09-Nov-18Transfer From
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
08207748
09-Nov-18Buy
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
1561.1GBX819844985
09-Nov-18Transfer From
Trade Notifier Information for GlaxoSmithKline
Simon Dingemans held the position of CFO at GlaxoSmithKline at the time of this trade.
 Simon Dingemans
0819844985
View more Glaxosmithkline directors dealings >>


ge0rge123
Posts: 579
Opinion:Buy
Price:1,562.60
Bought
Thu 16:55
Last night at COB for divi...let's hope today's show of strength holds ...as portfolio took a hammering for obvious reasons
Dinoken
Posts: 657
Opinion:No Opinion
Price:1,574.00
RE: Didn't think
Thu 11:01
Thank you Raab - ex divi day, should be 19p down but and sp is 19p up !
Apart from GSK being a good Brexit hedge, some good news abut pancreatic cancer tests :
https://pharmaphorum.com/news/gsk-begins-clinical-trials-of-pancreatic-cancer-combination/
riolto10
Posts: 1,788
Opinion:No Opinion
Price:1,560.20
RE: Didn't think
Thu 09:58
The pound and markets making this one of the better shares today !!
ge0rge123
Posts: 579
Opinion:Buy
Price:1,552.80
Didn't think
Wed 16:06
It would pull back as far as this today...where are the divi hunters?..I expect it will open 29p below today's closing SP tomorrow
iknowverylittle
Posts: 266
Opinion:No Opinion
Price:1,585.60
RE: ME
Tue 11:56
Will this hold £1580 after div or slope back down to sub £15?!
View more share chat for Glaxosmithkline (GSK) >>




Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 99,300 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries. As of August 2016 it had a market capitalisation of £81 billion the fourth largest on the London Stock Exchange



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.